Page results
-
Mr George Attilakos is a consultant in obstetrics and fetal medicine and the clinical lead for obstetrics at UCLH. Alongside managing normal pregnancies, Mr Attilakos has a special interest in the management of multiple pregnancies and high-risk pregnancies, as well as expertise in fetal medicine and fetal surgery, including in-utero treatment for congenital diaphragmatic hernia, spina bifida and twin-to-twin transfusion syndrome.
-
This booklet tells you about having a Vortex® Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
Temporary change to HIV confirmation pathway due to Bio-Rad kit supply issues
-
This page tells you about having a PICC (Peripherally Inserted Central Catheter) line insertion with the Interventional Radiology team.
-
This page tells you about having a Non-Tunnelled CVC Line Insertion (Vascath). This page is for those patients who have been referred to Interventional Radiology.
-
A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.
-
This page is for patients over 18 years old. It may also be useful to family, friends and carers. This page explains: treatment Escalation Plans (TEP) cardiopulmonary Resuscitation (CPR) how…
File results
-
FOI/2024/0462 - Patient information leaflets and e-consent systems
-
FOI/2024/0198 - Nurse intake at Band 5
-
FOI/2024/0199 - Admission and discharge policies for violent assault injuries/ autism/ patient records/ inaccurate records
-
FOI/2024/0204 - Clinical insourcing for audiology and pathology
-
FOI/2024/0206 - Trusts budget allocated for cancer funding 2019/20-2023/24
-
FOI/2024/0207 - Physician Associates and prescribing/ ionising radiation
-
FOI/2024/0214 - Treatment for myeloproliferative neoplasms
-
FOI/2024/0219 - Incidence and treatment of colorectal cancer
-
FOI/2024/0221 - Inbound patient enquiries
-
FOI/2024/0223 - Treatment of cancer secondary care